News Sentiment

BIOA sentiment intelligence

BioAge Labs, Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 53 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 24.34 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

88/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-3.0% over one week, +34.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

HitGen Partner BioAge Labs Doses First Participant In Phase 2 Trial Of BGE-102

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 88/100 classification
One-week reaction -3.0% Price reacting lower
Trend fit Trend active 34.9% over four weeks
Fair value 114.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 28
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 11
Stock Titan 6
Investing.com 4
Market source 4
GlobeNewswire 4
Sahm 3
Investing.com Canada 3
simplywall.st 3

Event Lens

What the news is about

Classified themes
Market update 40
Earnings 6
Analyst action 3
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-50 of 50